Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

190 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Transmembrane Protein TMEM230, Regulator of Glial Cell Vascular Mimicry and Endothelial Cell Angiogenesis in High-Grade Heterogeneous Infiltrating Gliomas and Glioblastoma.
Cocola C, Abeni E, Martino V, Piscitelli E, Pelucchi P, Mosca E, Chiodi A, Mohamed T, Palizban M, Porta G, Palizban H, Nano G, Acquati F, Bruno A, Greve B, Gerovska D, Magnaghi V, Mazzaccaro D, Bertalot G, Kehler J, Balbino C, Arauzo-Bravo MJ, Götte M, Zucchi I, Reinbold RA. Cocola C, et al. Among authors: greve b. Int J Mol Sci. 2024 Apr 3;25(7):3967. doi: 10.3390/ijms25073967. Int J Mol Sci. 2024. PMID: 38612777 Free PMC article.
Tumor suppressor miR-218 directly targets epidermal growth factor receptor (EGFR) expression in triple-negative breast cancer, sensitizing cells to irradiation.
Wischmann FJ, Troschel FM, Frankenberg M, Kemper B, Vijaya Kumar A, Sicking M, Ibrahim SA, Kiesel L, Götte M, Eich HT, Greve B. Wischmann FJ, et al. Among authors: greve b. J Cancer Res Clin Oncol. 2023 Sep;149(11):8455-8465. doi: 10.1007/s00432-023-04750-x. Epub 2023 Apr 23. J Cancer Res Clin Oncol. 2023. PMID: 37088795 Free PMC article.
Safety and efficacy of rozanolixizumab in patients with generalised myasthenia gravis (MycarinG): a randomised, double-blind, placebo-controlled, adaptive phase 3 study.
Bril V, Drużdż A, Grosskreutz J, Habib AA, Mantegazza R, Sacconi S, Utsugisawa K, Vissing J, Vu T, Boehnlein M, Bozorg A, Gayfieva M, Greve B, Woltering F, Kaminski HJ; MG0003 study team. Bril V, et al. Among authors: greve b. Lancet Neurol. 2023 May;22(5):383-394. doi: 10.1016/S1474-4422(23)00077-7. Lancet Neurol. 2023. PMID: 37059507 Clinical Trial.
Proteoglycan Expression Studied by MicroRNAs.
Espinoza-Sanchez NA, Troschel F, Greve B, Götte M. Espinoza-Sanchez NA, et al. Among authors: greve b. Methods Mol Biol. 2023;2619:273-292. doi: 10.1007/978-1-0716-2946-8_20. Methods Mol Biol. 2023. PMID: 36662477
190 results